LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,421,000 | +53.8% | 30,590 | 0.0% | 0.13% | +28.7% |
| Q1 2020 | $2,225,000 | -47.9% | 30,590 | -25.3% | 0.10% | -37.7% |
| Q4 2019 | $4,271,000 | -2.6% | 40,955 | -7.0% | 0.16% | -15.2% |
| Q3 2019 | $4,385,000 | -12.8% | 44,055 | 0.0% | 0.19% | -6.8% |
| Q2 2019 | $5,029,000 | +33.8% | 44,055 | +47.4% | 0.20% | +34.0% |
| Q1 2019 | $3,758,000 | +4.7% | 29,895 | +13.0% | 0.15% | -0.6% |
| Q4 2018 | $3,589,000 | +46.3% | 26,450 | +195.9% | 0.15% | +73.0% |
| Q3 2018 | $2,454,000 | -33.4% | 8,940 | -87.1% | 0.09% | -48.3% |
| Q4 2014 | $3,682,000 | +13.2% | 69,200 | 0.0% | 0.17% | +13.2% |
| Q3 2014 | $3,252,000 | – | 69,200 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |